AAV‐MAPK6, ApoE−/−MAPK6flox/floxTEKCre mice and the CXCL12 neutraligand were used to confirm the beneficial effects of MAPK6 against atherosclerosis. This evidence concerns the gene CXCL12 and atherosclerosis.